165 related articles for article (PubMed ID: 16155726)
1. Capsid-targeted viral inactivation can destroy dengue 2 virus from within in vitro.
Qin CF; Qin ED
Arch Virol; 2006 Feb; 151(2):379-85. PubMed ID: 16155726
[TBL] [Abstract][Full Text] [Related]
2. [Capsid-targeted viral inactivation for dengue virus infection].
Qin CF; Jiang T; Chen SP; Yu M; Qin ED
Wei Sheng Wu Xue Bao; 2005 Feb; 45(1):111-5. PubMed ID: 15847175
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures.
Qin CF; Qin E; Yu M; Chen SP; Jiang T; Deng YQ; Duan HY; Zhao H
Arch Virol; 2005 Apr; 150(4):659-69. PubMed ID: 15592886
[TBL] [Abstract][Full Text] [Related]
4. Capsid-targeted viral inactivation can eliminate the production of infectious murine leukemia virus in vitro.
VanBrocklin M; Federspiel MJ
Virology; 2000 Feb; 267(1):111-23. PubMed ID: 10648188
[TBL] [Abstract][Full Text] [Related]
5. Development of cell lines stably expressing staphylococcal nuclease fused to dengue 2 virus capsid protein for CTVI.
Qin CF; Qin ED
Acta Biochim Biophys Sin (Shanghai); 2004 Aug; 36(8):577-82. PubMed ID: 15295652
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition of the replication of classical swine fever virus by capsid-targeted virus inactivation.
Wang YF; Wang ZH; Li Y; Zhang XJ; Sun Y; Li M; Qiu HJ
Antiviral Res; 2010 Feb; 85(2):422-4. PubMed ID: 19857524
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of replication of classical swine fever virus in a stable cell line by the viral capsid and Staphylococcus aureus nuclease fusion protein.
Zhou B; Liu K; Wei JC; Mao X; Chen PY
J Virol Methods; 2010 Jul; 167(1):79-83. PubMed ID: 20304012
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibition of Japanese encephalitis virus replication by capsid-targeted virus inactivation.
Pang R; He DN; Zhou B; Liu K; Zhao J; Zhang XM; Chen PY
Antiviral Res; 2013 Mar; 97(3):369-75. PubMed ID: 23321201
[TBL] [Abstract][Full Text] [Related]
9. Attenuated dengue 2 viruses with deletions in capsid protein derived from an infectious full-length cDNA clone.
Zhu W; Qin C; Chen S; Jiang T; Yu M; Yu X; Qin E
Virus Res; 2007 Jun; 126(1-2):226-32. PubMed ID: 17412442
[TBL] [Abstract][Full Text] [Related]
10. In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus.
López C; Gil L; Lazo L; Menéndez I; Marcos E; Sánchez J; Valdés I; Falcón V; de la Rosa MC; Márquez G; Guillén G; Hermida L
Arch Virol; 2009; 154(4):695-8. PubMed ID: 19305942
[TBL] [Abstract][Full Text] [Related]
11. Recombinant multiepitope protein for early detection of dengue infections.
Anandarao R; Swaminathan S; Fernando S; Jana AM; Khanna N
Clin Vaccine Immunol; 2006 Jan; 13(1):59-67. PubMed ID: 16426001
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.
Lai CY; Hu HP; King CC; Wang WK
J Biomed Sci; 2008 Jan; 15(1):15-27. PubMed ID: 17768670
[TBL] [Abstract][Full Text] [Related]
13. A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus.
Lazo L; Hermida L; Zulueta A; Sánchez J; López C; Silva R; Guillén G; Guzmán MG
Vaccine; 2007 Jan; 25(6):1064-70. PubMed ID: 17097199
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of duck Tembusu virus capsid protein fused with staphylococcal nuclease protein to target Tembusu infection in vitro.
Zhang X; Jia R; Pan Y; Wang M; Chen S; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Liu Y; Zhang L; Yin Z; Jing B; Huang J; Tian B; Pan L; Yu Y; Ur Rehman M; Cheng A
Vet Microbiol; 2019 Aug; 235():295-300. PubMed ID: 31383316
[TBL] [Abstract][Full Text] [Related]
15. Sustained replication of dengue pseudoinfectious virus lacking the capsid gene by trans-complementation in capsid-producing mosquito cells.
Sangiambut S; Suphatrakul A; Sriburi R; Keelapang P; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
Virus Res; 2013 Jun; 174(1-2):37-46. PubMed ID: 23466247
[TBL] [Abstract][Full Text] [Related]
16. [Secreted expression of dengue virus type I envelope glycoprotein in 293T cells].
Miao F; Li C; Zhang S; Wang XF; Li JD; Zhang QF; Liu QZ; Wei Y; Hang XT; Liang MF; Li DX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):415-7. PubMed ID: 20718342
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to Fas-mediated apoptosis by dengue virus capsid protein.
Limjindaporn T; Netsawang J; Noisakran S; Thiemmeca S; Wongwiwat W; Sudsaward S; Avirutnan P; Puttikhunt C; Kasinrerk W; Sriburi R; Sittisombut N; Yenchitsomanus PT; Malasit P
Biochem Biophys Res Commun; 2007 Oct; 362(2):334-9. PubMed ID: 17707345
[TBL] [Abstract][Full Text] [Related]
18. Dengue virus capsid protein usurps lipid droplets for viral particle formation.
Samsa MM; Mondotte JA; Iglesias NG; Assunção-Miranda I; Barbosa-Lima G; Da Poian AT; Bozza PT; Gamarnik AV
PLoS Pathog; 2009 Oct; 5(10):e1000632. PubMed ID: 19851456
[TBL] [Abstract][Full Text] [Related]
19. A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.
Valdés I; Bernardo L; Gil L; Pavón A; Lazo L; López C; Romero Y; Menendez I; Falcón V; Betancourt L; Martín J; Chinea G; Silva R; Guzmán MG; Guillén G; Hermida L
Virology; 2009 Nov; 394(2):249-58. PubMed ID: 19783271
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and identification of dengue virus with deletion mutation of capsid protein].
Zhu WY; Qin ED; Yu M; Qin CF; Yu XD
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):31-4, 37. PubMed ID: 17259139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
